- Investing Ideas
- Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Belgian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
3
0 new
Mid-Large Cap Stocks
3 companies
Financière de Tubize
Market Cap: €10.2b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€228.80
7D
3.8%
1Y
76.0%
UCB
Market Cap: €49.9b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€262.30
7D
5.6%
1Y
59.2%
argenx
Market Cap: €47.1b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€758.00
7D
9.2%
1Y
49.2%